New research found that nearly 1 in 5 second-level appeals for denied cancer medications under Medicare Part D were ...

C, explains why a prostate cancer diagnosis should be seen as a change in direction, not an ending, and how patients can lean ...

Dr. Morana Vojnic answers common questions about brain cancer, including diagnosis, tumor types, treatment effects, ...

CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and clinical trial access.

Longer follow-up presented at the 2026 ESMO Congress showed that four already-approved treatments for early breast cancer, ...

The Hairy Cell Leukemia Foundation will host a free patient forum on July 17th with guest speaker Dr. Martin Tallman from Memorial Sloan Kettering Cancer Center. This forum is free and open to the ...

A clinical trial will test zanubrutinib plus sonrotoclax as a fixed-duration, chemotherapy-free treatment for hairy cell ...

C, discusses why he built the MyUrova app and how men with prostate, bladder, kidney or testicular cancer can prepare for ...

CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and clinical trial access.

Two phase 3 trials at ESMO 2026 brought new options for advanced endometrial cancer, and final results for Verzenio after another CDK4/6 drug showed a survival difference that was not statistically ...

Four phase 3 trials at ESMO 2026 brought news for people with small cell, EGFR, MET and KRAS G12C lung cancer, plus a caution ...

Kreitman of the National Cancer Institute has spent more than three decades working on hairy cell leukemia (HCL). He first encountered the disease in 1983 as a medic ...